These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16127435)

  • 1. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
    Barber DF; Bartolomé A; Hernandez C; Flores JM; Redondo C; Fernandez-Arias C; Camps M; Rückle T; Schwarz MK; Rodríguez S; Martinez-A C; Balomenos D; Rommel C; Carrera AC
    Nat Med; 2005 Sep; 11(9):933-5. PubMed ID: 16127435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
    Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
    J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J
    Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
    Appleby P; Webber DG; Bowen JG
    Clin Exp Immunol; 1989 Dec; 78(3):449-53. PubMed ID: 2612055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction.
    Seropian IM; Toldo S; Abbate A; Mezzaroma E; Van Tassell BW
    Circ Res; 2010 Jul; 107(2):e5; author reply e6-7. PubMed ID: 20651289
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibiting inflammation in rheumatoid arthritis.
    Firestein GS
    N Engl J Med; 2006 Jan; 354(1):80-2. PubMed ID: 16394307
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.
    Deng GM; Liu L; Bahjat FR; Pine PR; Tsokos GC
    Arthritis Rheum; 2010 Jul; 62(7):2086-92. PubMed ID: 20222110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
    J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-rich DNA suppresses systemic lupus.
    Patole PS; Zecher D; Pawar RD; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3273-80. PubMed ID: 16176997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus.
    Jimenez-Caliani AJ; Jimenez-Jorge S; Molinero P; Rubio A; Guerrero JM; Osuna C
    J Pineal Res; 2008 Sep; 45(2):204-11. PubMed ID: 18507713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells contribute to autoimmune kidney injury in MRL-Faslpr mice.
    Iwata Y; Furuichi K; Sakai N; Yamauchi H; Shinozaki Y; Zhou H; Kurokawa Y; Toyama T; Kitajima S; Okumura T; Yamada S; Maruyama I; Matsushima K; Kaneko S; Wada T
    J Rheumatol; 2009 Feb; 36(2):306-14. PubMed ID: 19208562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
    Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
    J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
    Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
    J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.
    Rodriguez W; Mold C; Marnell LL; Hutt J; Silverman GJ; Tran D; Du Clos TW
    Arthritis Rheum; 2006 Jan; 54(1):325-35. PubMed ID: 16385552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.